X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurosciences (12) 12
index medicus (11) 11
animals (10) 10
male (7) 7
mice, inbred c57bl (7) 7
parkinson's disease (7) 7
rat model (7) 7
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
medium spiny neurons (6) 6
mice (6) 6
levodopa-induced dyskinesia (5) 5
neurovetenskaper (5) 5
abnormal involuntary movements (4) 4
basic medicine (4) 4
dopamine (4) 4
dyskinesia, drug-induced - metabolism (4) 4
female (4) 4
life sciences (4) 4
medicinska och farmaceutiska grundvetenskaper (4) 4
neurology (4) 4
parkinsons-disease (4) 4
element-binding protein (3) 3
extracellular signal-regulated map kinases - metabolism (3) 3
l-dopa-induced dyskinesia (3) 3
levodopa - adverse effects (3) 3
mice, transgenic (3) 3
phenols (3) 3
rats (3) 3
signal transduction (3) 3
signal transduction - drug effects (3) 3
striatum (3) 3
antiparkinson agents - adverse effects (2) 2
antiparkinson agents - pharmacology (2) 2
basal ganglia (2) 2
brain - drug effects (2) 2
corpus striatum - drug effects (2) 2
corpus striatum - metabolism (2) 2
d1 receptor (2) 2
disease models, animal (2) 2
dopa-induced dyskinesia (2) 2
dyskinesia, drug-induced - etiology (2) 2
dyskinesia, drug-induced - genetics (2) 2
dyskinesia, drug-induced - pathology (2) 2
dyskinesia, drug-induced - physiopathology (2) 2
enzyme inhibitors - pharmacology (2) 2
erk1/2 (2) 2
extracellular signal-regulated kinase (2) 2
fosb expression (2) 2
gene expression regulation (2) 2
hemiparkinsonian mice (2) 2
histone h3 (2) 2
histones - metabolism (2) 2
humans (2) 2
in vitro techniques (2) 2
levodopa - pharmacology (2) 2
management (2) 2
medicine (2) 2
mglur5 (2) 2
mice, knockout (2) 2
mitogens (2) 2
movement disorders (2) 2
multidisciplinary sciences (2) 2
nerve tissue proteins - biosynthesis (2) 2
nervous system (2) 2
neurons (2) 2
neurons - metabolism (2) 2
oxidopamine (2) 2
parkinson disease, secondary - chemically induced (2) 2
parkinson disease, secondary - metabolism (2) 2
phosphorylation (2) 2
protein kinases (2) 2
receptors (2) 2
receptors, ampa - metabolism (2) 2
receptors, dopamine d1 - genetics (2) 2
receptors, dopamine d2 - genetics (2) 2
research article (2) 2
ribosomal protein s6 kinases, 90-kda - metabolism (2) 2
rodents (2) 2
signal-regulated kinase (2) 2
studies (2) 2
synaptic plasticity (2) 2
time factors (2) 2
tyrosine 3-monooxygenase - metabolism (2) 2
6-ohda (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.neu.nb ] life sciences [q-bio]/neurons and cognition [q-bio.nc]/neurobiology (1) 1
[sdv.bbm.gtp]life sciences [q-bio]/biochemistry, molecular biology/genomics [q-bio.gn] (1) 1
[sdv.neu.nb]life sciences [q-bio]/neurons and cognition [q-bio.nc]/neurobiology (1) 1
abridged index medicus (1) 1
action initiation (1) 1
activated protein-kinase (1) 1
adenosine a receptors (1) 1
adenylyl-cyclase (1) 1
adrenergic agents - toxicity (1) 1
aging (1) 1
aids (1) 1
aminoacetonitrile - analogs & derivatives (1) 1
aminoacetonitrile - pharmacology (1) 1
ampa receptor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 02/2009, Volume 108, Issue 3, pp. 621 - 633
In the dopamine-depleted striatum, extracellular signal-regulated kinase (ERK) signaling is implicated in the development of l-DOPA-induced dyskinesia. To gain... 
Striatum | Bacterial artificial chromosome | Mitogen- and stress-activated kinase 1 | Parkinson's disease | L-DOPA-induced dyskinesia | Transgenic mice | mitogen- and stress-activated kinase 1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | D-1 | ABNORMAL INVOLUNTARY MOVEMENTS | SYNAPTIC PLASTICITY | NEUROSCIENCES | RAT MODEL | bacterial artificial chromosome | LEVODOPA-INDUCED DYSKINESIA | PHOSPHATASE CASCADE | FOSB EXPRESSION | striatum | transgenic mice | l-DOPA-induced dyskinesia | RECEPTORS | PARKINSONS-DISEASE | Phosphorylation | Antiparkinson Agents - pharmacology | Sympatholytics | Male | Substantia Nigra - metabolism | Oxidopamine | Substantia Nigra - cytology | Ribosomal Protein S6 Kinases, 90-kDa - metabolism | Neurons - ultrastructure | Neostriatum - drug effects | Receptors, Dopamine D2 - drug effects | Parkinson Disease, Secondary - metabolism | Neostriatum - metabolism | Neurons - metabolism | Parkinson Disease, Secondary - chemically induced | Extracellular Signal-Regulated MAP Kinases - physiology | Neurons - drug effects | Levodopa - pharmacology | Neostriatum - cytology | Mice, Inbred C57BL | Receptors, Dopamine D1 - drug effects | Dyskinesias - physiopathology | Blotting, Western | Receptors, Dopamine D2 - genetics | Substantia Nigra - drug effects | Animals | Signal Transduction - drug effects | Fluorescent Antibody Technique | Mice | Histones - metabolism | Receptors, Dopamine D1 - genetics | Neurosciences | Phosphoproteins | Neurons | Fluorescence | Phenols | Mitogens | Dopamine receptors | Neurology | Signal transduction | Biochemistry | Rodents | Parkinsons disease | Index Medicus
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2017, Volume 127, Issue 2, pp. 720 - 734
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2012, Volume 32, Issue 17, pp. 5900 - 5910
Although l-3,4-dihydroxyphenylalanine (l-DOPA) remains the reference treatment of Parkinson's disease, its long-term beneficial effects are hindered by... 
Life Sciences | Neurons and Cognition | Neurobiology
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2017, Volume 127, Issue 2, pp. 720 - 734
Journal Article
Progress in Neurobiology, ISSN 0301-0082, 09/2015, Volume 132, Issue Jul 21, pp. 96 - 168
Journal Article